Klaus Wirth

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Professor Dr Klaus Josef Wirth is a medical doctor and Professor in Pharmacology at the Goethe University of Frankfurt, Germany and a researcher at KOSA Pharma GmbH.[1][2]

Between 2020 and 2021, with Prof. Dr Carmen Scheibenbogen, Prof. Wirth published a set of articles describing a detailed hypothesis of the pathophysiology of ME/CFS.[3][4][5]

Notable studies[edit | edit source]

  • 2020, A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors[3] - (Full text)
  • 2021, An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[5] - (Full text)
  • 2021, Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[4] - (Full text)

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]